Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for aspirin-lysoPAF interactions; leaves open any in vivo or clinical relevance.
Substantial amounts of platelet-activating factor (PAF) were formed when lysoPAF was mixed with aspirin (e.g. 0.04% of added lysoPAF (200 nmol) was converted to PAF when mixed with aspirin (2 mumol) for 1 h). Non-enzymatic formation of PAF from aspirin and lysoPAF also occurs in the aqueous solution or in organic solvents in time-dependent and dose-dependent manners. Possible meanings of the non-enzymatic formation of PAF are discussed.
No takes yet. Share an insight, caveat, or question.
Mabuchi-Itoh et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: